During the past decade, Xijing Hospital of Digestive Diseases conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 1 clinical trials were completed, i.e. on average, 1.6% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Xijing Hospital of Digestive Diseases" #1 sponsor was "Air Force Military Medical University, China" with 52 trials, followed by "Xijing Hospital of Digestive Diseases" with 30 trials sponsored, "Xijing Hospital" with 3 trials sponsored, "Nanfang Hospital of Southern Medical University" with 1 trials sponsored and "Xinjiang Biochemical Pharmaceutical Co., Ltd." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Xijing Hospital of Digestive Diseases" #1 collaborator was "The Second Affiliated Hospital of Chongqing Medical University" with 5 trials as a collaborator, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 3 trials as a collaborator, "Eastern Hepatobiliary Surgery Hospital" with 3 trials as a collaborator, "Fudan University" with 3 trials as a collaborator and "Huaihe Hospital of Henan University" with 3 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 41 trials.

According to Clinical.Site data, the most researched conditions in "Xijing Hospital of Digestive Diseases" are "Dyspepsia" (8 trials), "Adenoma" (7 trials), "Bowel Preparation" (7 trials), "Gastric Cancer" (7 trials) and "Helicobacter Pylori Infection" (7 trials). Many other conditions were trialed in "Xijing Hospital of Digestive Diseases" in a lesser frequency.

Most popular intervention types in "Xijing Hospital of Digestive Diseases" are "Drug" (31 trials), "Other" (27 trials), "Device" (11 trials), "Procedure" (10 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bismuth" (7 trials), "Berberine" (5 trials), "Amoxicillin" (4 trials), "Water colonoscopy" (4 trials) and "Esomeprazole" (3 trials). Other intervention names were less common.

The vast majority of trials in "Xijing Hospital of Digestive Diseases" are 87 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Xijing Hospital of Digestive Diseases". undefined are not yet recruiting, 10 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Xijing Hospital of Digestive Diseases, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Xijing Hospital of Digestive Diseases, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 40 trials that are defined as “Not Applicable".